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Abstract
Background Surveillance of premalignant gastric lesions
relies mainly on random biopsy sampling. Narrow band
imaging (NBI) may enhance the accuracy of endoscopic
surveillance of intestinal metaplasia (IM) and dysplasia.
We aimed to compare the yield of NBI to white light
endoscopy (WLE) in the surveillance of patients with IM
and dysplasia.
Methods Patients with previously identified gastric IM or
dysplasia underwent a surveillance endoscopy. Both WLE
and NBI were performed in all patients during a single
procedure. The sensitivity of WLE and NBI for the
detection of premalignant lesions was calculated by cor-
relating endoscopic findings to histological diagnosis.
Results Forty-three patients (28 males and 15 females,
mean age 59 years) were included. IM was diagnosed in 27
patients; 20 were detected by NBI and WLE, four solely by
NBI and three by random biopsies only. Dysplasia was
detected in seven patients by WLE and NBI and in two
patients by random biopsies only. Sixty-eight endoscopi-
cally detected lesions contained IM: 47 were detected by
WLE and NBI, 21 by NBI only. Nine endoscopically
detected lesions demonstrated dysplasia: eight were
detected by WLE and NBI, one was detected by NBI only.
The sensitivity, specificity, positive and negative predictive
values for detection of premalignant lesions were 71, 58,
65 and 65% for NBI and 51, 67, 62 and 55% for WLE,
respectively.
Conclusions NBI increases the diagnostic yield for
detection of advanced premalignant gastric lesions com-
pared to routine WLE.
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Abbreviations
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Introduction
Helicobacter pylori is an important risk factor for gastric
cancer due to the fact that it causes chronic inflammation of
the gastric mucosa in virtually all infected patients. In the
multi-step model of gastric carcinogenesis, this chronic
inflammation may slowly progress through the pre-malig-
nant stages of atrophic gastritis, intestinal metaplasia and
dysplasia to gastric adenocarcinoma [1]. We have previ-
ously shown that the actual cancer risk for patients with
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any of the pre-malignant conditions of the stomach is very
similar to the cancer risk in patients with a Barrett’s
oesophagus or in those after removal of colonic adenoma
[2]. Surveillance of these pre-malignant lesions could lead
to early detection of patients with disease progression, and
thus to early intervention aiming at cancer prevention and
improved survival of these patients. However, recent
investigation has demonstrated that current surveillance of
pre-malignant gastric lesions is at great discrepancy with
the substantial gastric cancer risk of these lesions [2].
Furthermore, studies have shown that a considerable pro-
portion of patients with dysplastic lesions are being missed
in current routine gastroenterology practice [3].
The gold standard for diagnosing these gastric lesions is
histology of biopsy specimens. The major shortcoming of
this approach is the fact that pre-malignant lesions may
occur multifocally, and may thus be missed on random
biopsy sampling. Although image quality of standard
endoscopes has improved dramatically over the past dec-
ades, endoscopic evaluation of the condition of the gastric
mucosa still correlates poorly with histological findings
[4–7]. Therefore, a diagnosis of pre-malignant gastric
lesions remains dependent on random biopsy sampling
during conventional gastroscopy.
Several new imaging techniques to overcome limitations
of conventional white light endoscopy (WLE) have been
developed over recent decades. A promising technique is
narrow-band imaging (NBI). The principle of this new
technique is based on modification of the spectral charac-
teristics of the optical filter in the light source, which leads
to improved visibility of mucosal structures. With the use
of different narrow-band filters in combination with image
magnification, mucosal structures can be very clearly
demonstrated, among others, resulting in increased contrast
between surface and vascular pattern [8].
Several studies described the diagnostic accuracy of NBI
in detecting gastrointestinal lesions [8, 9]. Based on these
results, one might expect that the use of this technique for
targeted biopsy sampling can increase the diagnostic yield
of endoscopy for primary detection of pre-malignant gastric
lesions. However, the additional value of NBI in the sur-
veillance of patients with pre-malignant gastric lesions is
yet unclear and requires further investigation.
Therefore the aim of this study was to compare the yield
of NBI over conventional white light endoscopy (WLE) in
the surveillance of patients with intestinal metaplasia and
dysplasia, using histology as a reference value.
Methods
This single center, prospective study was carried out in the
Erasmus MC in Rotterdam. The study protocol was
approved by the local Institutional Review Board. All
patients provided informed consent.
Patient Selection and Endoscopic Procedure
Patients with previously identified intestinal metaplasia or
dysplasia of the gastric mucosa underwent a surveillance
endoscopy. Patients with coagulopathy uncorrected at the
time of endoscopy or a thrombocytopenia (\50 9 109/l)
were excluded. After informed consent, both WLE and
NBI were performed in all patients by a single endoscopist
specialized in NBI and WLE endoscopy of the gastric
mucosa during a single procedure with a GIF180 endo-
scope (Olympus Optical, Hamburg, Germany). The pro-
cedure started with conventional white light endoscopy.
During endoscopy, all suspicious antral and angular gastric
lesions were photographed, videotaped, and documented
on a specially designed scoring sheet in terms of size (cm)
and morphology (according to the Paris classification).
During the same setting, the stomach was carefully
observed using the NBI system. Again, all suspicious antral
and angular gastric lesions were photographed, videotaped,
and documented on the specially designed scoring sheet.
NBI suspicious lesions for intestinal metaplasia were
defined as bluish-whitish areas with an irregular mucosal
pattern, a complete loss of architectural and mucosal pat-
tern was suspicious for dysplasia. At least one targeted
biopsy was taken from all endoscopic lesions suspected for
intestinal metaplasia or dysplasia by NBI or WLE. Fur-
thermore, four random biopsies were obtained: two from
the antrum and two from the angulus.
Histological Assessment
Biopsy specimens obtained from the stomach were fixed in
buffered formalin and embedded in paraffin. The speci-
mens were sectioned at 4-lm thickness, and stained by
haematoxylin and eosin. An expert pathologist specialized
in GI pathology reviewed the sections and was blinded to
endoscopic and clinical findings. Inflammation, atrophy,
metaplasia and dysplasia were classified according to the
updated Sydney System and revised Vienna classification
[10–12].
Statistical Analysis
The number of patients with intestinal metaplasia or dys-
plasia detected by NBI and WLE was evaluated. Further-
more, the number of endoscopically detected lesions which
were suspected for intestinal metaplasia or dysplasia by NBI
and/or WLE were evaluated. These endoscopically sus-
pected lesions were considered as the unit of analysis in this
evaluation, even though some patients had more than one
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lesion. For the random biopsies, the overall diagnosis of the
antrum biopsies and the overall diagnosis of the angulus
biopsies were considered as unsuspected lesions by NBI or
WLE. Each endoscopically suspected lesion (identified by
NBI and WLE) or unsuspected lesion (random biopsy) was
considered as an independent observation for statistical
purposes. For each patient and each lesion only the most
severe pre-malignant grading was evaluated. For instance,
patients with intestinal metaplasia and with a concomitant
diagnosis of dysplasia were classified as having dysplasia.
Sensitivity, specificity, positive and negative predictive
values for the prediction of intestinal metaplasia and dys-
plasia for NBI and WLE were calculated using histology as
a reference value. Differences between NBI and WLE were
assessed by using McNemar’s test and by analyzing
receiver operating characteristic (ROC) curves. In addition,
a bootstrap resampling model (using c-stat) was performed
to calculate the difference between the discriminatory
power of both techniques [13, 14]. The data were submitted
for statistical testing using the Statistical Package for the
Social Sciences (SPSS), version 11.0.
Results
From May 2007 until December 2008, 43 patients (28
males, 15 females) with a mean age of 58.7 years (range
34–75 years) were included. Of these patients, 32 (74%)
patients had a previous diagnosis of intestinal metaplasia
and 11 (26%) patients had a previous diagnosis of dys-
plasia. The majority of patients (88%) were of Dutch
descent. The baseline characteristics of the patients are
presented in Table 1. The mean interval between initial
diagnosis and surveillance endoscopy was 2.0 years (range
0.8–21.1 years) for patients with intestinal metaplasia and
1.9 years (range 0.2–5.2 years) for patients with dysplasia.
Per Patient Analysis
Of the 43 patients that were included, 27 (63%) demon-
strated intestinal metaplasia at surveillance endoscopy and
nine (21%) patients demonstrated dysplasia (low grade
dysplasia n = 6; high grade dyplasia n = 3) (Table 2;
Figs. 1 and 2). In the remaining seven (16%) patients no
diagnosis of intestinal metaplasia or dysplasia was con-
firmed at surveillance endoscopy. Baseline endoscopy had
shown intestinal metaplasia in antrum and corpus mucosa
in five (12%) and two (4%) of these patients, respectively.
Of the 27 intestinal metaplasia patients, 20 (74%) were
detected by both WLE and NBI, whereas four (15%) were
detected solely by NBI. The remaining three (11%) patients
were detected by random biopsy sampling only. Of the nine
dysplasia patients, seven (78%) patients (low grade
dysplasia n = 4 and high grade dysplasia n = 3) were
detected by both WLE and NBI and not by random biop-
sies. In the remaining two (22%) patients, random biopsies
demonstrated foci with low grade dysplasia; NBI and WLE
detected marked intestinal metaplasia but no dysplasia in
these two patients.
Per Lesion Analysis
In total, 121 lesions in the gastric mucosa were endo-
scopically suspected for intestinal metaplasia or dysplasia
Table 1 Baseline characteristics of patient population
Characteristic Intestinal metaplasia
n = 32 (%)
Dysplasiaa
n = 11 (%)
Age, mean (SD) 57.5 (10.7) 63.1 (9.8)
Gender
Male 20 (62) 8 (73)
Female 12 (37) 3 (27)
Ethnicity
Caucasian 29 (91) 9 (82)
Non-Caucasian 3 (9) 2 (18)
Smoking
Non-smoker 19 (59) 3 (27)
Current smoker 11 (34) 3 (27)
Former smoker 2 (6) 4 (36)b
Alcohol
Non-drinker 17 (53) 5 (45)
Current drinker 15 (47) 5 (45)b
Medication use
PPI 15 (47) 4 (36)
NSAIDs 3 (9) 2 (18)
H. pylori eradication therapy 9 (28) 5 (45)
SD standard deviation, PPI proton pump inhibitors, NSAID nonste-
roidal antiinflammatory drugs
a Low grade dysplasia n = 10; high grade dysplasia n = 1
b One patient refused to answer questions concerning smoking and
drinking habits
Table 2 Patients with histologically confirmed diagnosis of intestinal
metaplasia (IM) or dysplasia (DYS)
Detection method Histologically confirmed Total, N = 36a
IM, n = 27 DYS, n = 9
WLE & NBI 20 7 27
NBI 4 – 4
WLE – – –
Random biopsies 3 2 5
WLE white light endoscopy, NBI narrow band imaging
a In the remaining seven patients no diagnosis of intestinal metaplasia
or dysplasia was confirmed
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after WLE and NBI (Table 3). Eighty-six (71%) of these
endoscopic lesions were suspected for intestinal metaplasia
or dysplasia by both WLE and NBI. Two (2%) were only
suspected by WLE, and 33 (27%) were only suspected by
NBI.
Seventy-seven (64%) of these 121 endoscopically sus-
pected lesions had a histopathological diagnosis of intes-
tinal metaplasia (n = 68) or dysplasia (n = 9). For
intestinal metaplasia (n = 68), 47 (69%) endoscopical
lesions were detected both by WLE and NBI, the remain-
ing 21 (30%) lesions were solely detected by NBI. For
dysplasia (n = 9), eight (89%) endoscopic lesions (low
grade dysplasia n = 5, and high grade dysplasia n = 3)
were detected by WLE and NBI, whereas one (11%) lesion
with low grade dysplasia was detected by NBI only.
Although all 121 endoscopic lesions were suspected for
intestinal metaplasia or dysplasia by NBI or WLE, 44
(36%) of these 121 suspected lesions did not show intes-
tinal metaplasia or dysplasia when histologically assessed.
Thirty-one (70%) of these false positive lesions were sus-
pected both by WLE and NBI, two (5%) were suspected
only by WLE, and 11 (25%) were suspected by NBI only.
The overall diagnosis of the random biopsies resulted in
27 additional endoscopically suspected lesions which
showed intestinal metaplasia and 4 lesions which showed
low grade dysplasia. All these regions had not been sus-
pected endoscopically by NBI or WLE.
Based on these results, the sensitivity, specificity, posi-
tive and negative predictive values of WLE endoscopy
were 51, 67, 62 and 55%, respectively. For NBI, the
Fig. 1 White light endoscopy
(WLE) image and narrow band
imaging (NBI) of intestinal
metaplasia at the angulus
Fig. 2 White light endoscopy
(WLE) image and narrow band
imaging (NBI) of dysplasia at
the angulus
Table 3 Endoscopically suspected lesions and a histologically confirmed diagnosis of intestinal metaplasia (IM) or dysplasia (DYS)
Detection method Histologically confirmed Total, N = 121
IM, n = 68 DYS, n = 9 No IM/DYS, n = 44
WLE & NBI 47 8 31 86
NBI 21 1 11 33
WLE – – 2 2
WLE white light endoscopy, NBI narrow band imaging
Dig Dis Sci (2010) 55:3442–3448 3445
123
sensitivity, specificity, positive predictive value and nega-
tive predictive value were 71, 58, 65 and 65%, respec-
tively. Specificity was marginally higher for WLE (P =
0.04), whereas sensitivity was considerably lower for WLE
than for NBI (P \ 0.001). In addition, according to boot-
strap resampling, NBI was superior in detecting intestinal
metaplasia and dysplasia versus normal mucosa than WLE
(P = 0.03).
Discussion
This study provides evidence that NBI yields more accurate
results in the surveillance of patients with intestinal meta-
plasia and dysplasia than conventional WLE. First, we
demonstrated that 15% of the patients with intestinal meta-
plasia at surveillance endoscopy were solely detected by
NBI. Second, considerably more endoscopically detected
lesions with intestinal metaplasia were detected by NBI
compared to WLE. And third, the sensitivity for the detec-
tion of advanced precursor lesions increased by 20–71% for
NBI.
Similar to our observations, previous studies demon-
strated promising results for NBI for the detection of pre-
neoplastic lesions in the gastrointestinal tract, in particular
for colon and esophagus [15]. The additional value of NBI
in the detection of gastric pre-malignant lesions remained
less clear, especially in countries with a low gastric cancer
incidence.
A Japanese study described a sensitivity and specificity
of 89 and 93%, respectively, for the detection of gastric
intestinal metaplasia with NBI endoscopy [8]. This high
accuracy compared to our findings is probably explained by
training differences that exist between Japanese and Wes-
tern gastroenterologists. Due to the high gastric cancer
incidence, Japanese endoscopists are trained to scrutinize
gastric mucosal areas which are compatible with atrophy
and early cancer. Moreover, considerably more time is
spent on a thorough mucosal examination, than in Western
countries [16]. Another possible explanation for the high
sensitivity and specificity found in the previous study was
the use of NBI in combination magnification endoscopy [8].
In Japan, it has been demonstrated that magnification
endoscopy can accurately detect gastric cancer during
routine endoscopy [17–19]. However, our study shows that
in Western countries with an overall low gastric cancer
incidence, even without adding magnification, NBI endos-
copy is of additional value for the detection of pre-malig-
nant gastric lesions, in particular in a surveillance setting.
Currently, the diagnosis of intestinal metaplasia and
dysplasia is based on histological evaluation of biopsy
specimens. Since endoscopic diagnosis of pre-malignant
lesions shows high interobserver variability and has poor
correlation to histological diagnosis, numerous other
endoscopic techniques have been developed to overcome
these limitations in the last decades.
Similar to NBI, the use of auto-fluorescence endoscopy
demonstrated a high correlation between Barrett’s esoph-
agus and histological diagnosis. However, the correlation
between gastric cancer and this imaging technique still
remains controversial [20–22]. For chromoendoscopy, a
previous study demonstrated a facilitated detection of early
gastric cancer in hereditary diffuse gastric cancer [23].
Moreover, compared to auto-fluorescence endoscopy, the
equipment necessary for chromoendoscopy is widely
available and the technique is often quick and inexpensive.
For some new staining techniques however, safety remains
questionable [24].
Confocal endomicroscopy is a newly developed endo-
scopic technique that produces 1000-fold magnification
cross-sectional images. This new technique can accurately
predict the presence of early cancer in targeted areas, and a
recently published gastric pit-pattern classification for the
prediction for gastritis and atrophy showed a high corre-
lation with histology [25, 26]. Nevertheless, confocal
endomicroscopy is not able to completely replace histology
and interobserver and intraobserver agreement for this pit-
pattern classification remains unknown. Furthermore, the
technique is too elaborate to be used for assessment of the
complete gastric mucosa.
Compared to these new techniques, magnification
endoscopy demonstrated the best sensitivities and speci-
ficities for a diagnosis of atrophic gastritis or gastric can-
cer. However, similar to NBI, most of these previous
studies were of Japanese origin and mostly included low
numbers of patients [17, 18, 27, 28]. In addition, despite the
promising results of magnification endoscopy, uniform
classification criteria of this technique have to date not
been confirmed in large controlled trials in Western or
Eastern countries.
Since our study shows that NBI has a low specificity and
suboptimal sensitivity for the detection of preneoplastic
gastric lesions, a combination of both NBI as well as
magnification is likely to provide the best alternative with
current endoscopical practice. Previous studies already
demonstrated a high correlation between microvascular
patterns found with NBI in combination with magnifica-
tion, and a diagnosis of gastric cancer [9, 29]. Therefore,
further research in a prospective study design is necessary
to evaluate whether NBI in combination with magnification
also yields adequate results for the detection and surveil-
lance of patients with intestinal metaplasia or dysplasia in
Western countries.
Previous studies demonstrated that surveillance of
patients with pre-malignant gastric lesions should prefera-
bly be limited to patients at high risk of gastric cancer [2].
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A risk score based on histology only (OLGIM staging
system) or a broader risk classification including several
clinical and laboratory parameters have been described
[30, 31]. For either method, adequate biopsy sampling at
baseline is essential. In this study we show that NBI has the
potential to increase and optimize the yield of biopsies with
intestinal metaplasia. However, although NBI shows an
improved sensitivity for the detection of premalignant
gastric lesions over WLE, random biopsy sampling is still
necessary in the surveillance of patients with pre-malignant
gastric lesions. This is illustrated by the fact that three
patients with intestinal metaplasia and two patients with
dysplasia were not detected after WLE and NBI endoscopy
and were only diagnosed with these pre-malignant lesions
after histological evaluation of the random biopsies.
Therefore, targeted and random biopsies seem essential for
accurate surveillance of patients with pre-malignant gastric
lesions. A further study in our department concerning the
use of random and targeted biopsies demonstrated that nine
random biopsies from cardia, corpus, and in particular
along the lesser curvature, angulus and antrum are required
for optimal detection of pre-malignant gastric lesions in a
population at low gastric cancer risk [32]. However, similar
to this previous study, in a small percentage of patients in
our study, intestinal metaplasia was not confirmed during
surveillance endoscopy [32]. Since these patients all
underwent endoscopy with extensive biopsy sampling, we
assume that the majority, if not all of these patients had a
patchy and limited extent of metaplasia and thus a low
gastric cancer risk.
Some limitations of this study warrant consideration.
First, the endoscopic procedure of WLE and NBI was
performed by the same endoscopist. Therefore, detection of
intestinal metaplasia and dysplasia by NBI could possibly
be biased by the previous white light observations, result-
ing in an overestimation of the detection rate of NBI.
Second, only recently it has been demonstrated that the
severity and extent of atrophic gastritis and intestinal
metaplasia are adequate predictors of gastric cancer risk
[31, 33]. Antrum and angulus were selected in this study
because these are the regions of particular interest with the
highest prevalence of intestinal metaplasia. Nevertheless,
the protocol used in this study is also applicable to the
proximal part of the gastric mucosa. A large further study
is necessary to confirm that NBI in combination with
random biopsy sampling may accurately detect extensive
intestinal metaplasia in patients with pre-malignant gastric
lesions. Third, although NBI showed an increased detection
rate for intestinal metaplasia and dysplasia, it was also
related to a higher rate of false positivity than WLE
(Table 3). This higher rate does not however imply
increasing costs for surveillance, as the decision to embark
on surveillance remains dependent on confirmation of
endoscopic findings by histology.
In conclusion, NBI considerably increases the diagnostic
yield of the detection of advanced premalignant gastric
lesions compared to routine WLE. Therefore, NBI seems
superior to WLE in the surveillance of patients with these
advanced lesions of the gastric mucosa.
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